Remove center-orphan-drug-research rare-disease-day rare-disease-day-2019
article thumbnail

Rare Disease Day and a Focus on Quality

PQA

Today is Rare Disease Day. It’s an opportunity to raise awareness of the impact of rare diseases. There are more than 10,000 known rare diseases and only a few hundred have safe, effective treatments. In the United States, rare disease affects about one in 10 people.

article thumbnail

Expediting innovation in the rare disease domain

pharmaphorum

Rare diseases affect a fraction of the population – 450 million + people globally. However, its effects can be equally severe and life-threatening as other prevalent diseases. For Rare Disease Day, Tarun Kumar Bansal discusses why we need to expedite innovation in the rare disease domain.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top 20 IPOs in Healthcare by Total Fund Value

PharmaShots

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. The lead program of the company, THIO, is an investigational dual mechanism of action drug incorporating telomere targeting and immunogenicity in patients with NSCLC.

article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. Cablivi stops platelets from clumping together, which prevents small clots, and can be used along with other drugs that suppress the immune system.